Ionis Pharmaceuticals Inc.
Income Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Revenue | $121.6M | $107.2M |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $134.6M | $106.4M |
| SG&A Expense | $14.5M | $13.8M |
| Operating Income | $-27.5M | $-13.1M |
| Operating Margin | -22.6% | -12.2% |
| Interest Expense | $12.7M | $11.8M |
| Pretax Income | $-31.8M | — |
| Income Tax Expense | $3.2M | — |
| Net Income | $155.1M | $-18.2M |
| Net Margin | 127.5% | -17.0% |
| EPS (Basic) | $1.58 | $-0.19 |
| EPS (Diluted) | $1.58 | $-0.19 |
| Shares Outstanding (Basic) | 98.1M | 94.6M |
| Shares Outstanding (Diluted) | 98.1M | 94.6M |
| Dividends Per Share | — | — |